InvestorsObserver
×
News Home

Is Adverum Biotechnologies Inc (ADVM) Stock at the Top of the Biotechnology Industry?

Friday, February 16, 2024 12:54 PM | InvestorsObserver Analysts

Mentioned in this article

Is Adverum Biotechnologies Inc (ADVM) Stock at the Top of the Biotechnology Industry?

Adverum Biotechnologies Inc (ADVM) is near the top in its industry group according to InvestorsObserver. ADVM gets an overall rating of 87. That means it scores higher than 87 percent of stocks. Adverum Biotechnologies Inc gets a 97 rank in the Biotechnology industry. Biotechnology is number 16 out of 148 industries.

Overall Score - 87
ADVM has an Overall Score of 87. Find out what this means to you and get the rest of the rankings on ADVM!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Adverum Biotechnologies Inc Stock Today?

Adverum Biotechnologies Inc (ADVM) stock is trading at $2.16 as of 12:50 PM on Friday, Feb 16, a gain of $0.16, or 8% from the previous closing price of $2.00. The stock has traded between $1.95 and $2.20 so far today. Volume today is less active than usual. So far 701,640 shares have traded compared to average volume of 3,049,443 shares. Click Here to get the full Stock Report for Adverum Biotechnologies Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App